Circulating Tumor DNA (ctDNA) Clearance May Predict Treatment Response in Neoadjuvant Colorectal Cancer Management

Conclusions: This study highlights the potential utility of ctDNA and the need for prospective trials in the neoadjuvant setting to monitor treatment response and guide decisions on treatment duration.PMID:38541909 | DOI:10.3390/jcm13061684

Source: Clinical Colorectal Cancer - March 28, 2024 Category: Cancer & Oncology Authors: Britney Niemann John Moise Michael Sestito Midhun Malla Kevin Train Douglas Murken Keri Mayers Emily Groves Mary Garland-Kledzik Source Type: research